Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Eledon Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +3 vs. Q1 2023
- Shares held
- 9.28M
- +3.03M (+48.6%) vs. Q1 2023
- Total value
- $12.7M
- −$2.02M (−13.7%) vs. Q1 2023
- New holders
- 6
- 10 more added
- Sold out
- 3
- 6 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 161 | $184.6M |
| Q1 2026 | 121 | $131.2M |
| Q4 2025 | 95 | $66.7M |
| Q3 2025 | 83 | $94.5M |
| Q2 2025 | 85 | $110.7M |
| Q1 2025 | 83 | $130.3M |
| Q4 2024 | 75 | $158.5M |
| Q3 2024 | 33 | $46.0M |
| Q2 2024 | 32 | $48.2M |
| Q1 2024 | 29 | $19.8M |
| Q4 2023 | 29 | $16.5M |
| Q3 2023 | 28 | $12.2M |
| Q2 2023 | 33 | $12.7M |
| Q1 2023 | 30 | $14.7M |
| Q4 2022 | 28 | $14.4M |
| Q3 2022 | 31 | $17.3M |
| Q2 2022 | 31 | $15.9M |
| Q1 2022 | 32 | $27.6M |
| Q4 2021 | 36 | $34.7M |
| Q3 2021 | 35 | $52.1M |
| Q2 2021 | 34 | $74.5M |
| Q1 2021 | 34 | $89.0M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Eledon Pharmaceuticals, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 220 | $0 | 0.00% | +151+218.8% | Added |
| UBS Group AG | 32 | $44 | 0.00% | −424−93.0% | Reduced |
| Wells Fargo & Company | 146 | $200 | 0.00% | +60+69.8% | Added |
| Morgan Stanley | 2,155 | $2.95K | 0.00% | +2,155 | New |
| Group One Trading, L.P. | 5,918 | $8.11K | 0.00% | +5,318+886.3% | Added |
| Citadel Advisors LLC | 7,740 | $10.6K | 0.00% | −23,070−74.9% | Reduced |
| Two Sigma Investments, LP | 10,586 | $14.5K | 0.00% | −7,000−39.8% | Reduced |
| Tower Research Capital LLC (TRC) | 11,450 | $15.7K | 0.00% | +5,199+83.2% | Added |
| Veritable, L.P. | 13,029 | $17.9K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 14,987 | $20.5K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 15,783 | $21.6K | 0.00% | +15,783 | New |
| Mercer Global Advisors Inc | 16,726 | $23.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 17,675 | $24.0K | 0.00% | +17,675 | New |
| SVB Financial Group | 18,025 | $24.7K | 0.05% | −8,917−33.1% | Reduced |
| Boothbay Fund Management, LLC | 22,050 | $30.2K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 23,000 | $31.5K | 0.00% | −2,100−8.4% | Reduced |
| BlackRock Inc. | 28,302 | $38.8K | 0.00% | −24,266−46.2% | Reduced |
| Northern Trust Corp | 30,053 | $41.2K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 43,002 | $58.9K | 0.00% | +30,397+241.2% | Added |
| State Street Corp | 44,692 | $61.2K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 50,502 | $69.2K | 0.00% | +50,502 | New |
| Ingalls & Snyder LLC | 50,849 | $70.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 60,373 | $83.0K | 0.00% | +28,200+87.7% | Added |
| Jmac Enterprises LLC | 80,041 | $109.7K | 0.03% | +25,503+46.8% | Added |
| Geode Capital Management, LLC | 169,650 | $232.4K | 0.00% | +40,499+31.4% | Added |
| Ikarian Capital, LLC | 221,830 | $303.9K | 0.11% | 00.0% | Unchanged |
| CM Management, LLC | 234,803 | $322.0K | 0.31% | +30.0% | Added |
| Royal Bank of Canada | 273,345 | $374.0K | 0.00% | +273,345 | New |
| Ensign Peak Advisors, Inc | 443,001 | $606.9K | 0.00% | 00.0% | Unchanged |
| Woodline Partners LP | 516,675 | $707.8K | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 679,557 | $931.0K | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 1,842,803 | $2.52M | 0.06% | +1,842,803 | New |
| BVF Inc | 4,326,710 | $5.93M | 0.17% | +2,000,000+86.0% | Added |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −1,217,882−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −17,954−100.0% | Sold out |
| Ameritas Advisory Services, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |